Personalis (PSNL) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Personalis (PSNL) is Neutral.

The composite score behind that read is +0.03, weighing +0.27 of bullish evidence against -0.17 bearish.

Personalis last closed at $16.00, -0.37% on the session.

Against the IVW growth benchmark the position is -1.17% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

9 graded predictions for PSNL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Personalis in the 19th percentile on return on equity, where 100 is best.

Personalis is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $1.72B.

StockMap tracks Personalis as the 28th largest of the 41 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 37 Neutral, 2 Moderate Outperform and 2 Moderate Underperform.

On that composite Personalis ranks 29th of 41 in the group, against a group median of +0.06.